BGNE

BeiGene, Ltd. (BGNE)

Last Price$226.70.0%
Market Cap$1,846.9M
LTM Quick ratio
1.6x
5Y avg
4.1x
Biotechnology industry median
4.2x
Stock quality & Intrinsic value
5/10
11.4% undervalued

BeiGene, Ltd. Quick ratio

Annual
Quarterly
LTM
Industry median
Company stand-alone
BGNE
Healthcare
Crunching data... Almost there!
Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Quick ratio
0.1x
3.3x
2.9x
10.5x
5.8x
7.4x
3.7x
4.4x
4.4x
4.6x
2.0x
BGNE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BGNE and see if it's the right time to invest.
Dive in

BeiGene, Ltd. (BGNE) Quick ratio comparison analysis

Crunching data... Almost there!

BGNE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is BeiGene, Ltd.'s Quick ratio?

As of today, Microsoft Corp's last 12-month Quick ratio is 1.6x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Quick ratio for BeiGene, Ltd. have been 3.2x over the past three years, and 4.3x over the past five years.

2) Is BeiGene, Ltd.'s Quick ratio Good?

As of today, BeiGene, Ltd.'s Quick ratio is 1.6x, which is lower than industry median of 4.2x. It indicates that BeiGene, Ltd.'s Quick ratio is Bad.

3) How does BeiGene, Ltd.'s Quick ratio compare to its peers?

As of today, BeiGene, Ltd.'s Quick ratio is 1.6x, which is lower than peer median of 2.4x. The list of peers includes REGN, SMMT, BNTX, UTHR, ALNY, VRTX, INCY, NVO, RPRX, ARGX.